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Research
Exposure to vehicular pollutants is associated 
with exacerbation of both cardiovascular and 
respiratory diseases (Ibald-Mulli et al. 2002; 
Peters et al. 2004; Pope 2000; Timonen 
et al. 2006; Wichmann et al. 2000). Diesel 
engine exhaust (DE) is an important con-
tributor to urban air pollution (Brunekreef 
and Holgate 2002; Laden et al. 2000; Pope 
et al. 1999). Although the exact components 
of DE responsible for its effects have yet to 
be defined, both short-term and chronic DE 
exposure are associated with arrhythmias and 
adverse cardiac events (Dockery et al. 2005; 
Peters et al. 2000; Rich et al. 2005) and 
cause endothelial dysfunction that dimin-
ishes vasodilator response in systemic arteries 
(Hansen et al. 2007). Multiple pathways reg-
ulate endothelium-dependent vasodilatation, 
including the release of nitric oxide (NO) and 
prostacyclin from the nitric oxide synthase 
(NOS) and cyclooxygenase (COX) pathways, 
respectively. Additionally, activation of small 
(SK) and intermediate (IK) Ca2+-dependent 
potassium channels can result in the hyper-
polarization and ultimately the relaxation of 
vascular smooth muscle. However, short-term 
inhalation of dilute DE has been shown to 
inhibit forearm vasodilation to both acetyl-
choline (ACh) and the NO donor, sodium 
nitroprusside, in healthy volunteers (Mills 
et al. 2005; Tornqvist et al. 2007), suggest-
ing that DE exposure may specifically affect 
signaling downstream of NO.
Endothelial NOS (eNOS) is a homo-
dimeric protein that generates NO from the 
conversion of l-arginine to l-citrulline. NO 
inhibits platelet aggregation, leukocyte adher-
ence, and vascular smooth muscle prolifera-
tion to regulate vascular homeostasis (Alheid 
et al. 1987; Kubes et al. 1991; Nunokawa 
and Tanaka 1992). Synthesized NO dif-
fuses into adjacent vascular smooth muscle, 
where it activates soluble guanylate cyclase to 
reduce intracellular Ca2+ concentration and 
decrease vascular tone, leading to vasodila-
tion. The eNOS cofactor 5,6,7,8-tetrahydro-
biopterin (BH4) is required for the production 
of NO, possibly by stabilizing the physical 
and/or electro  chemical coupling of the NOS 
dimer, and is generated from guanosine-5´-
triphosphate (GTP) through a de novo pathway 
or recycled from the oxidized form of BH4, 
7,8-dihydrobiopterin (BH2) by dihydrofolate 
reductase (DHFR) (Sugiyama et al. 2009).
DE exposure increases oxidative stress 
within the vasculature (Miller et al. 2009), 
which can potentially increase the oxida-
tion of BH4 to BH2, thereby limiting the 
bioavailability of this essential cofactor. 
Depletion of BH4 or increases in BH2 electro-
chemically uncouple eNOS, resulting in the 
generation of superoxide radical (O2
–) rather 
than NO (Crabtree et al. 2008; Sugiyama 
et al. 2009). In a cascade fashion, peroxy  nitrite 
(ONOO–) production from the reaction of 
O2
– and NO not only depletes bioavailable 
NO, but can also oxidize BH4 to catalyze fur-
ther eNOS uncoupling. We have previously 
reported that vasoconstriction is augmented in 
systemic arteries from DE-exposed rodents and 
that the augmented constriction is endothe-
lium dependent and can be reversed with 
NOS inhibition (Campen et al. 2005; Cherng 
et al. 2009; Knuckles et al. 2008). The aim of 
this study was to evaluate agonist-mediated 
vasodilation in coronary arteries from healthy 
rats exposed to DE. We hypothesized that 
DE-induced reactive oxygen species (ROS) 
uncouple NOS to diminish NO-dependent 
vasodilatation in coronary arteries.
Methods
Animals. All animal protocols were reviewed 
and approved by the Institutional Animal 
Care and Use Committee of the Lovelace 
Respiratory Research Institute (LRRI) and the 
University of New Mexico and conform to 
National Institutes of Health guidelines for 
animal use to ensure animals were treated 
humanely and with regard for the alleviation 
of suffering (Institute of Laboratory Animal 
Resources 1996). Male Sprague-Dawley rats 
(250–300 g; Charles River Laboratories, 
Portage, MI) were housed in quarantine for 
14 days after receipt, then acclimated to expo-
sure chambers for 7–14 days. Within 2-m3 
stainless steel and plexiglas chambers (Hazleton 
Systems, Maywood, NJ), rats were housed in 
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Ba c k g r o u n d a n d o B j e c t i v e: Increased air pollutants correlate with increased incidence of cardio-
vascular disease potentially due to vascular dysfunction. We have reported that acute diesel engine 
exhaust (DE) exposure enhances vasoconstriction and diminishes acetylcholine (ACh)-induced dila-
tion in coronary arteries in a nitric oxide synthase (NOS)-dependent manner. We hypothesize that 
acute DE inhalation leads to endothelial dysfunction by uncoupling NOS.
Me t h o d s : Rats inhaled fresh DE (300 µg particulate matter/m3) or filtered air for 5 hr. After off-
  gassing, intraseptal coronary arteries were isolated and dilation to ACh recorded using video  microscopy.
re s u l t s: Arteries from DE-exposed animals dilated less to ACh than arteries from air-exposed 
animals. NOS inhibition did not affect ACh dilation in control arteries but increased dilation in 
the DE group, suggesting NOS does not normally contribute to ACh-induced dilation in coronary 
arteries but does contribute to endothelial dysfunction after DE inhalation. Cyclooxygenase (COX) 
inhibition did not affect ACh dilation in the DE group, but combined inhibition of NOS and COX 
diminished dilation in both groups and eliminated intergroup differences, suggesting that the two 
pathways interact. Superoxide scavenging increased ACh dilation in DE arteries, eliminating dif-
ferences between groups. Tetrahydrobiopterin (BH4) supplementation with sepiapterin restored 
ACh-mediated dilation in the DE group in a NOS-dependent manner. Superoxide generation 
(dihydroethidium staining) was greater in DE arteries, and superoxide scavenging, BH4 supplemen-
tation, or NOS inhibition reduced the signal in DE but not air arteries.
co n c l u s i o n: Acute DE exposure appears to uncouple NOS, increasing reactive oxygen species 
generation and causing endothelial dysfunction, potentially because of depletion of BH4 limiting its 
bioavailability.
key w o r d s : arteries, cardiovascular, engine emissions, exhaust, nitric oxide synthase, Nω-nitro-
l-arginine, particulate matter, rat. Environ Health Perspect 119:98–103 (2011).  doi:10.1289/
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standard shoebox cages and maintained on a 
12:12 hr light:dark cycle, with food and water 
available ad libitum before exposures. Food was 
withdrawn during DE exposure.
DE exposure. Rats were exposed to 300 µg 
particulate matter (PM)/m3 DE in a sealed 
chamber for 5 hr representing the daily PM 
exposure limit set by the U.S. Environmental 
Protection Agency (2010). Although daily 
exposure in most of the U.S. population is far 
lower in terms of PM, occupations requiring 
the use of diesel engines have exposure condi-
tions similar to this study (Pronk et al. 2009). 
The DE system has been previously character-
ized and produces levels of CO and nitro-
gen oxide (NOx) at approximately 3 ppm and 
4 ppm, respectively (McDonald et al. 2004). 
Control (Air) rats were housed identically but 
exposed to filtered air. DE was generated from 
a single-cylinder, 5,500-watt, Yanmar diesel 
generator (Yanmar, Adairsville, GA) using 
nationally certified diesel fuel at the LRRI 
facility. Electrical current was drained from the 
engine to provide a constant 90% load dur-
ing operation to ensure consistent emissions. 
The particle concentration was monitored by 
sampling on 47-mm Pallflex (Pall-Gelman, 
Port Washington, NY) filters. Filters were 
collected twice per day (every 3 hr) for each 
DE exposure chamber and once per day from 
the control chamber. Prefilter and postfilter 
weights were measured with a microbalance, 
and desired concentrations of the emissions 
were attained by diluting the direct exhaust 
with filtered air. Exposure chamber tempera-
ture and humidity were monitored throughout 
exposures, and temperatures were maintained 
at 20–25°C (McDonald et al. 2004).
Isolated artery preparation. At the end of 
the 5-hr exposure, chambers were off-gassed for 
30 min, and the rats were removed and eutha-
nized with sodium pentobarbital (200 mg/
kg, intraperitoneal). Hearts were immediately 
removed and intraseptal coronary arteries (rest-
ing inner diameter, Air: 176 ± 7 µm, DE: 180 
± 7 µm) were isolated and placed in chilled 
physiological saline solution (PSS, in micro-
moles per liter; 129.8 NaCl, 5.4 KCl, 0.83 
MgSO4, 19 NaHCO3, 1.8 CaCl2, and 5.5 
glucose) aerated with 21% O2, 6% CO2, and 
73% N2. Each artery was used for only one 
experimental protocol. Both ends of the arter-
ies were cannulated onto glass micropipettes in 
a tissue chamber (Living Systems, CH-1; LSI, 
Burlington, VT) and secured with silk sutures 
within 30 min of isolation from the heart. 
Vessels were stretched to approximate in situ 
length and pressurized to 60 mmHg with PSS 
in the lumen absent of flow and superfused 
at a rate of 5 mL/min with 37oC oxygenated 
PSS. At the end of the experiment, Ca2+-free 
PSS (3.7 mmol/L EGTA) was superfused for 
60 min to fully relax the vessel (Ca2+-free inner 
diameter, Air: 219 ± 4 µm, DE: 224 ± 4 µm).
Vasodilator studies. Vessel chambers were 
placed on the stage of an inverted Nikon 
Eclipse TS 100 (Nikon Instruments, Irvine, 
CA) microscope fitted with a video camera 
connected to a data acquisition computer. 
Inner diameter changes were recorded using 
edge detection software (IonOptix, Milton, 
MA) as described previously (Duling et al. 
2006). Arteries were treated for at least 30 min 
with various drug treatments or vehicle (Veh) 
in the superfusate and in the lumen before 
dilation with increasing concentrations of ACh 
(0.001–100 µmol/L) in U46619 (a throm-
boxane mimetic) preconstricted arteries (con-
stricted to ~ 50% of fully relaxed diameter). 
The contribution of key endothelial dilator 
pathways was determined using NOS inhibitor 
[Nω-nitro-l-arginine (l-NNA), 100 µmol/L], 
COX inhibitor (indomethacin or aspirin, 
10 µmol/L), and small (apamin, 100 nmol/L) 
and intermediate (Tram-34, 1 µmol/L) Ca2+-
activated K+ channels. The role of NOS 
uncoupling and ROS-mediated endothelial 
dysfunction after exposure was assessed with 
BH4 donor (sepiapterin, 1 µmol/L) and the cell 
permeate superoxide dismutase (PEG-SOD, 
150 U/mL), respectively.
Quantitative real-time polymerase chain 
reaction analysis. RNA from intraseptal cor-
onary artery homogenate was isolated using 
Qiagen RNeasy Fibrous Tissue Mini Kit 
(Qiagen USA, Valencia, CA) according to 
manufacturer’s protocol. Reverse transcriptase 
synthesis of cDNA and real-time quantitative 
polymerase chain reaction (qPCR) were per-
formed as described elsewhere (de Frutos et al. 
2008). In brief, multiplex qPCR amplification 
of TaqMan probe sets (Applied Biosystems, 
Carlsbad, CA) for DHFR and GTP cyclo-
hydrolase (GTPCH) with respect to β-actin 
was performed using a 7500 Fast Real-Time 
PCR System (Applied Biosystems). Relative 
expression (ΔΔCT) was calculated by subtract-
ing the CT of the endogenous β-actin control 
gene from the CT value of the gene of interest 
where the normalized gene expression method 
(2-ΔΔCT) was used for relative quantification of 
gene expression (Livak and Schmittgen 2001).
ROS measurement. Oxidation of the cell-
permeable fluorescent probe dihydroethidium 
(DHE) by O2
– generates ethidium+, which 
then intercalates into DNA of cells (Zhao 
et al. 2003, 2005). Septum from both Air- and 
DE-exposed animals were embedded in O.C.T. 
Compound (TissueTek; Sakuta Fineteck USA, 
Torrence, CA) without fixation and flash-frozen 
with liquid nitrogen. Septal sections (10 µm) 
were allowed to dry on glass slides for 30 min 
at room temperatures preceded by treatment 
with phosphate-buffered saline (PBS), l-NNA 
(100 µmol/L), sepiapterin (1 µmol/L), or the 
superoxide scavenger tiron (10 µmol/L) for 30 
min at 37°C, followed by incubation with DHE 
(10 µmol/L) with inhibitors for 45 min at 37°C. 
Cover slips were mounted on each slide with 
Vectashield (Vector Laboratories, Burlingame, 
CA). Images of coronary arteries were captured 
on a Nikon Optiphot fluorescence microscope 
(Nikon Instruments) using a Chroma TRITC 
filter set (Chroma Technology Corp, Bellows 
Falls, VT) (excitation: 510–560 nm; emission: 
570–650 nm). Data are expressed as aver-
age intensity (integrated intensity per area of 
region of interest) from one artery per rat for 
six rats in each group and were gathered using 
Metamorph software (version 7.0; Molecular 
Devices, Sunnyvale, CA).
Statistical analysis and calculations. Dilator 
responses were analyzed using two-way repeat-
ed-measures analysis of variance (ANOVA) 
with Student–Newman–Keuls post hoc analy-
sis (Sigma Stat, version 3.5; Systat Software, 
Inc., San Jose, CA) for differences between 
groups, concentrations, and interactions. 
Probability levels < 0.05 were considered sig-
nificant. Data were tested for normality as part 
of the two-way ANOVA analysis. All dilation 
data are expressed as a percent reversal of active 
tone (50% U46619 preconstricted) and is cal-
culated as the percent change in inner diameter 
as shown below.
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Results
DE inhibits ACh-mediated vasodilatation. 
First, we determined whether diesel exposure 
affected endothelium-dependent responses to 
ACh. Coronary arteries from DE-exposed rats 
(n = 9) had diminished vasodilation to ACh 
compared with arteries from air-exposed rats 
(n = 5, p = 0.006, Figure 1A). Maximal ago-
nist-induced dilation in Air (94 ± 4% ) was 
greater than DE arteries (44 ± 12%, p = 0.007). 
In Ca2+-free PSS, the inner diameter of fully 
relaxed coronary arteries was not different 
between Air and DE groups (200 ± 6 µm vs. 
210 ± 13 µm, respectively). These findings note 
a substantial reduction in dilatory response after 
a single acute exposure to DE.
NOS, but not COX, inhibition restores 
dilation after DE. To elucidate which 
  endothelium-dependent pathways were altered 
by DE exposure, we investigated the roles of 
NOS, COX, and SK and IK channels. NOS 
inhibition (n = 6) augmented ACh-mediated 
dilation in the DE group compared with vehi-
cle treatment (p = 0.011, Figure 1B), restor-
ing dilation to that in untreated Air arteries 
(p = 0.945), suggesting an NOS-dependent 
inhibition of dilation. Unexpectedly, l-NNA 
(100 µmol/L) did not alter dilation in the 
Air group compared with untreated controls 
(p = 0.456, Figure 1C). In contrast, COX 
inhibition with aspirin (10 µmol/L) modestly Cherng et al.
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inhibited dilation in the Air arteries (n = 6, 
p = 0.040, Figure 2A), but did not affect ACh-
mediated responses in the DE group (n = 9, 
Figure 2B).
The combined inhibition of NOS and 
COX blunted ACh-mediated dilation in 
both DE and Air group (n = 10 and n = 11, 
respectively, Figure 3A) compared with vehicle 
treatment within group. Blockade of SK and 
IK with Tram-34 (100 nmol/L) and apamin 
(1 µmol/L), respectively, diminished ACh-
mediated dilation significantly and similarly in 
both groups (n = 6 per group, Figure 3B) com-
pared with vehicle treatment, but the residual 
dilation was less in DE than in Air arteries. 
Finally, combined inhibition of NOS, COX, 
SK, and IK completely abolished dilation 
in both groups (data not shown). Although 
inhalation of DE alters other endothelium-
dependent dilator pathways, the impairment 
of NOS function, primarily, results in dimin-
ished ACh-mediated dilation.
Diminished dilation after DE is restored 
with BH4. To determine whether supplemen-
tation with the cofactor BH4 could rescue 
NOS function, arteries were treated with sepi-
apterin (1 µmol/L), which increases BH4 lev-
els through the salvage pathway, via DHFR, 
of BH4 biosynthesis. Sepiapterin treatment 
of isolated arteries augmented and restored 
ACh-mediated dilation in DE arteries (n = 5, 
Figure 4A) while blunting dilation in the 
Air group (n = 8, Figure 4C). The effects of 
sepiapterin on dilation were blocked by con-
current NOS inhibition (n = 5 per group, 
Figures 4B and 4D) such that there was no 
difference from vehicle treatment within each 
group. After exposure, BH4 levels appear to 
be insufficient to maintain NOS function.
The reduction in BH4 levels may result 
from a decrease in the BH4 biosynthesis path-
way after DE exposure. A decrease in GTPCH 
would blunt de novo synthesis of BH4 whereas 
inhibition of DHFR reduces the recov-
ery of BH2 back to BH4. Quantitative real-
time PCR revealed that DE exposure (n = 7) 
does not impact intra  septal coronary artery 
mRNA expression of GTPCH (p = 0.797) or 
DHFR (p = 0.558; data not shown) compared 
with Air (n = 8) exposure.
Superoxide scavenging prevents effects 
of DE exposure. DE exposure can increase 
oxidative stress, which can reduce both NO 
and BH4 levels (Katusic 2001; Miller et al. 
2009). Coronary artery superoxide levels were 
evaluated with the cell-permeable fluorescent 
probe DHE. Septal coronary arteries from 
rats exposed to DE induced greater DHE 
fluorescence than arteries from Air-exposed 
rats. Scavenging O2
– with tiron or inhibi-
tion of NOS had no effect on DHE fluores-
cence in Air, but diminished and normalized 
fluorescence in DE compared with Air (n = 
6 per group) (Figure 5), indicating increased 
O2
– generation after DE exposure that is 
NOS dependent. BH4 supplementation in 
the presence or absence of NOS inhibition 
similarly diminished DHE fluorescence only 
in DE coronary arteries, reducing it to the 
levels seen in Air arteries and supporting the 
conclusion that BH4 bioavailability may be 
depleted after DE exposure. ROS were scav-
enged with SOD to determine if oxidative 
stress mediates the vascular changes of DE 
exposure. Treatment of Air arteries with PEG-
SOD (150 U/mL) had no effect on ACh-
mediated vasodilation compared with vehicle 
treatment. Similar to NOS inhibition or BH4 
supplementation, superoxide scavenging with 
PEG-SOD restored dilation in the DE group 
Figure 1. ACh vasodilation was diminished after exposure to DE compared with Air control in vehicle (Veh)-treated coronary arteries (A). NOS inhibition with 
l-NNA (100 µmol/L) restored the blunted ACh-mediated dilation (B) without affecting dilation in the Air group (C). 
*p < 0.05 compared with Air or Veh.
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Figure 3. Inhibition of both NOS (l-NNA, 100 µmol/L) and COX (aspirin, 10 µmol/L) diminished dilation to ACh 
in both groups and eliminated between-groups differences (A). Although blockade of small and intermedi-
ate Ca2+-dependent K+ channels blunted dilation in arteries from both groups, dilation was still less in the 
DE-exposed compared with the Air group (B). 
*p < 0.05 compared with Air.
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so that dilation was not different from arteries 
in the Air vehicle treatment group (n = 4 per 
group) (Figure 6). Exposure to DE appears to 
augment superoxide generation that inhibits 
agonist-induced dilation.
Discussion
In our study, acute exposure to DE impaired 
ACh-mediated dilation in coronary arteries 
from healthy rats, an effect that was reversed 
by NOS inhibition. Supplementation with 
the BH4 precursor sepiapterin or scavenging 
ROS in vitro also completely restored ACh-
mediated dilation after DE exposure. Although 
COX inhibition did not alter dilation in either 
group, combined blockade of NOS and COX 
significantly blunted dilation in arteries from 
both Air and DE-exposed animals. Additional 
inhibition of SK and IK channels completely 
abolished dilation, with no difference between 
DE and filtered air groups. Combined, these 
observations suggest that DE exposure dimin-
ishes ACh-mediated dilation by selectively dis-
rupting NOS-mediated responses.
The most likely mechanism for loss of 
ACh-induced dilation in the DE arteries is 
oxidative stress-induced uncoupling of NOS. 
As sepiapterin supplementation antagonized 
the effects of DE, the current results sug-
gest that NOS may be uncoupled because 
of a loss of BH4. Uncoupled NOS generates 
O2
– rather than NO, which can further scav-
enge BH4 (Katusic 2001; Munzel et al. 2005; 
Nurkiewicz et al. 2010). BH4 is necessary for 
physical and electrochemical coupling of NOS, 
and the depletion of this cofactor in an oxida-
tive environment further exacerbates NOS and 
endothelial dysfunction. In this study, mRNA 
levels of GTPCH and DHFR were not altered 
by DE exposure, suggesting the de novo and sal-
vaging pathways of BH4 biosynthesis were not 
impaired. However, supplementation with sepi-
apterin, a precursor to BH4, fully restored ACh-
mediated dilation in coronary arteries from the 
DE-exposed group, suggesting that loss of this 
cofactor led to the impaired dilation.
Inhibition of NOS in DE-exposed rats pre-
vented the effects of sepiapterin, suggesting the 
effect of BH4 was to recouple NOS. In con-
trast, BH4 supplementation in coronary arter-
ies from Air-exposed animals had the opposite 
effect, diminishing endothelium-mediated 
dilation. These effects also appear to be NOS 
dependent, as treatment with l-NNA pre-
vented sepiapterin blunting of dilation in the 
Air arteries. Sepiapterin increases levels of BH2, 
the oxidized form of BH4, which is converted 
to BH4 by dihydrofolate reductase through 
the salvage pathway (Thony et al. 2000). If 
the salvage pathway is saturated by excess BH2 
levels, sepiapterin release of BH2 can inhibit 
NOS function by competing with BH4 for 
NOS binding to mimic BH4 depletion and 
increase ROS production by uncoupling NOS 
(Crabtree et al. 2008; Sugiyama et al. 2009). 
In this manner, sepiapterin may generate an 
oxidative environment in the Air arteries that 
is partially NOS driven, similar to the effects 
of DE exposure. Inhibition of NOS in arteries 
from Air-exposed animals treated with sepi-
apterin blunts ROS generation and restores 
endothelial function.
Basal levels of superoxide detected by DHE 
staining in coronary arteries were elevated after 
DE exposure compared with the Air group. 
This increase in superoxide generation was fur-
ther indicated by the increased tiron-sensitive 
signal that was blocked with NOS inhibition 
or BH4 supplementation. These data suggest 
DE exposure uncouples NOS by decreasing 
BH4 levels to augment ROS generation. NOS 
Figure 4. Dilation to ACh was augmented in arteries from the DE group after BH4 supplementation (sepiap-
terin, 1 µmol/L) compared with vehicle (Veh) treatment (A). In the presence of NOS inhibition (l-NNA, 100 
µmol/L), the effect of sepiapterin was blocked (B). Dilator response to ACh was blunted in arteries from the 
Air group after BH4 supplementation compared with Veh treatment (C). In the presence of NOS inhibition, 
the effect of sepiapterin was blocked (D). 
*p < 0.05 compared with Veh.
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inhibition in the presence of sepiapterin was 
not different from sepiapterin alone, which 
suggests that BH4 supplementation restored 
NOS function to a level that could be inhibited 
with l-NNA. It was recently described that the 
specificity of DHE fluorescence may not repre-
sent the intracellular levels of superoxide accu-
rately using fluorescent microscopy (Zielonka 
and Kalyanaraman 2010). Nonetheless, our 
study attempted to address the flaws of this 
methodology by comparing the component 
sensitive to tiron, a superoxide scavenger, 
rather than the raw values. Further support-
ing that DE effects were mediated by elevated 
levels of ROS, scavenging ROS with PEG-
SOD in coronary arteries from DE-exposed 
animals restored agonist-mediated dilation but 
did not alter dilation in the Air group. SOD 
catalyses the conversion of O2
– to hydrogen 
peroxide, which is further broken down to 
H2O and O2 by catalase. The restoration of 
ACh-induced dilation with PEG-SOD may be 
partially mediated by increased H2O2, which 
has been shown to be a vasodilator (Miura 
et al. 2003). However, taken with the observa-
tions that NOS inhibition and BH4 supple-
mentation also restore endothelial function, 
the present data are more consistent with the 
conclusion that after DE inhalation, uncou-
pled NOS generates O2
–. The increase in O2
– 
depletes bioavailability of both NO and BH4 
to potentiate further uncoupling of NOS. In 
contrast to our findings, Courtois et al. (2008) 
found NO-dependent relaxation was impaired 
after intratracheal PM instillation secondary to 
inflammation that decreased smooth muscle 
sensitivity to NO independent of ROS genera-
tion. As previously reported, acute inhalation 
of DE at moderate levels (i.e., 300 µg/m3) does 
not induce measureable changes in pulmonary 
inflammatory markers nor does it alter vascular 
smooth muscle sensitivity to basal NO (Cherng 
et al. 2009). A major difference between our 
study design and that of Courtois et al. (2008) 
as well as Nurkiewicz et al. (2006) is that we 
investigated effects immediately after exposures 
rather than 6–72 hr later. Thus, inflammatory 
contributions to the systemic vasculature are 
minimal in our model, as evidenced by lack 
of cytokine induction, whereas at later time 
points, evidence of rolling and adhering leu-
kocytes and dexamethasone-sensitive vascular 
impairments can be seen. The differences in 
exposure method, instillation of urban PM 
versus inhalation of dilute whole DE, and of 
vascular bed of interest, pulmonary versus sys-
temic, between Courtois et al. and the present 
study may have led to the different mecha-
nisms of NO impairment observed in these 
two studies. In fact, these differences provide 
insight into the multiple mechanisms leading 
to endothelial dysfunction after inhaled versus 
instilled exposure to air pollution.
Contrary to our hypothesis that sepiapterin 
treatment in AIR arteries augments BH2 levels 
to uncouple NOS, DHE fluorescence was not 
increased by addition of the BH2 donor in Air 
arteries. It has been demonstrated that BH4 is 
a weak antioxidant and that this may partially 
mediate its ability to restore endothelial func-
tion (Vasquez-Vivar et al. 2002). Therefore, 
sepiapterin treatment may have elevated BH2 
levels in the AIR arteries to increase NOS pro-
duction of O2
–, which was then scavenged 
by BH4, so that DHE fluorescence appeared 
unchanged but ACh dilation was still impaired. 
Additional studies directly measuring NO pro-
duction before and after BH4 treatment will 
be necessary to determine whether sepiapterin 
indeed impairs NOS function. Alternatively, 
sepiapterin-derived BH4 could facilitate NO 
synthesis to inhibit COX-dependent produc-
tion of vasodi  lators to impair ACh-mediated 
dilation (Boulos et al. 2000). In this case, NOS 
inhibition would have decreased NO synthesis 
to restore COX-mediated dilation, similar to 
NOS inhibition alone in the Air arteries.
Interactions between the NOS and COX 
pathways have been demonstrated previously 
in both cultured cells and isolated arteries 
(Bratz and Kanagy 2004) and are apparent 
in the current study. In Air arteries, COX 
inhibitors only modestly diminished ACh-
mediated dilation, whereas NOS inhibition 
had no effect; however, the combined inhibi-
tion greatly blunted agonist-induced dilation. 
These results suggest the two pathways exhibit 
functional redundancy such that pharmaco-
logical blockade of one pathway can be offset 
by activation through the alternate pathway. 
Thus, inhibition of both NOS and COX 
blunts dilation more than the sum of inhib-
iting either pathway alone. The synergistic 
effect of combined inhibition of NOS and 
COX was seen in both Air and DE arteries, 
suggesting that NOS/COX interaction is not 
lost after DE exposure and plays an essential 
role in the coronary artery.
Blockade of the SK and IK channels 
inhibited dilation in both groups, but dilation 
was still blunted in the DE compared with 
Air arteries in the presence of the inhibitors. 
Therefore, activation of SK and IK chan-
nels contribute to ACh-induced dilation but 
do not appear to be altered by DE expo-
sure. Interpretation of these results is com-
plicated, because these potassium channels 
regulate endothelial Ca2+ entry, which affects 
both NOS and COX activity. Inhibition of 
these channels induces membrane depolariza-
tion that reduces the electrochemical driving 
force for Ca2+ entry upon agonist stimulation 
(Faraci and Heistad 1998), potentially reduc-
ing both NOS and COX activation. In sum, 
the data show that ACh-induced dilation in 
coronary arteries is mediated by NOS, COX, 
SK, and IK, as combined inhibition of these 
pathways was necessary to completely abolish 
dilator responses.
Both human and animal studies suggest 
the NOS pathway is impaired by DE expo-
sure, but mechanistic details have not been 
fully elucidated. Recently, Nurkiewicz and 
colleagues (2009) found that NO availabil-
ity is reduced in vessels isolated from rats 
exposed acutely to ultrafine PM. However, it 
was not clear whether NOS was uncoupled 
or whether generated NO was scavenged; 
both mechanisms appear likely. Previously, 
we demonstrated that inhaled DE enhances 
endothelin-1 (ET-1) vasoconstriction in rat 
coronary arteries by stimulating uncoupled 
NOS-dependent constriction via endothelial 
endothelin B receptor (Cherng et al. 2009). 
Langrish et al. (2009) demonstrated similar 
findings in healthy human volunteers exposed 
to DE, where circulating ET-1 was not dif-
ferent but ET-1 constrictor sensitivity was 
enhanced, apparently via endothelin B recep-
tor pathways. In the present study, DE expo-
sure also diminishes ACh-mediated dilation, 
which was restored by NOS inhibition or BH4 
supplementation, further supporting the con-
clusion that DE exposure uncouples eNOS. 
ROS scavenging also reversed the effects of 
DE inhalation, supporting a role for increased 
oxidative stress, which can decrease NOS 
mediated dilation through multiple pathways. 
Elevated ROS levels presumably oxidize BH4, 
thereby decreasing availability of this neces-
sary cofactor for NO generation and resulting 
in NOS uncoupling. BH4 supplementation 
provides enough excess cofactor that NOS 
stays in a coupled state, preventing the effects 
of DE inhalation. Furthermore, NO can be 
scavenged by ROS to form ONOO–, which 
not only depletes NO bioavailability but can 
nitrosylate proteins to alter function (Alderton 
et al. 2001). Further studies are needed to 
determine if the initial source of ROS is DE or 
uncoupled NOS. It may be that DE provides 
the initial oxidative burst that leads to the 
uncoupling of NOS, resulting in a feed-for-
ward cycle leading to endothelial dysfunction. 
Alternatively, DE may provide a substrate for 
NOS uncoupling that is not related to ROS.
Figure 6. Scavenging of superoxide with PEG-SOD 
(150 U/mL) restored the dilator response to ACh in 
the DE group but did not affect responses in the 
Air group.
log [M] ACh
P
e
r
c
e
n
t
 
d
i
l
a
t
i
o
n
–20
0
20
40
60
80
100
120
–10 –9 –8 –7 –6 –5 –4 –3
Air (n = 4)
DE (n = 4)Diesel exhaust and NOS dysfunction
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 1 | January 2011  103
It is clear that pharmacologically induced 
vasodilatation is blunted in healthy volun-
teers (Mills et al. 2005; Tornqvist et al. 2007) 
and in animal models (Cherng et al. 2009; 
Knuckles et al. 2008) after acute inhalation 
of DE. It is unclear whether the alterations in 
vascular function in the current study persist 
at later time points; future studies will address 
this issue. We speculate similar changes 
will be present but waning over the follow-
ing 24–72 hr as the vascular alterations in 
humans, which have rapid onset (Mills et al. 
2005) and parallel our observations in the 
coronary arteries, persist at least 24 hr after 
cessation of exposure (Tornqvist et al. 2007). 
Potentially, activation of uncoupled NOS 
after DE inhalation may result in prolonged 
endothelial dysfunction that is only slowly 
reversed after exposure. It is likely that vascu-
lar endothelium must recover by the de novo 
production of NOS protein along with cofac-
tors such as BH4 which, depending on the 
potency of exposure, abundance of precursors 
and nutrients, and genetic factors, could take 
several days to recuperate. Furthermore, DE 
inhalation can increase circulating levels of the 
endogenous vasoconstrictor ET-1 in both ani-
mal (Vincent et al. 2001) and human (Peretz 
et al. 2008) studies and enhance vascular 
responsiveness to ET-1 (Cherng et al. 2009). 
Such changes would be expected to further 
diminish dilation and enhance constriction 
in coronary vessels, thereby increasing risk 
and/or severity of coronary occlusive seque-
lae. Thus, susceptible individuals with under-
lying cardiovascular conditions may have 
augmented coronary vasoconstriction after 
DE exposure, contributing to the increased 
cardiovascular events seen epidemiologically 
after elevated pollution levels.
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